metformin has been researched along with vasoactive intestinal peptide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ardill, J; Molloy, AM; Tomkin, GH | 1 |
| Al-Badri, G; Castorina, A; Karunia, J; Keay, KA; Mandwie, M; McGrath, K; Musumeci, G; Niaz, A; Rennie, C | 1 |
2 other study(ies) available for metformin and vasoactive intestinal peptide
| Article | Year |
|---|---|
The effect of metformin treatment on gastric acid secretion and gastrointestinal hormone levels in normal subjects.
Topics: Adult; Fasting; Gastric Inhibitory Polypeptide; Gastric Juice; Gastrointestinal Hormones; Glucagon; Humans; Metformin; Vasoactive Intestinal Peptide | 1980 |
Metformin Treatment Attenuates Brain Inflammation and Rescues PACAP/VIP Neuropeptide Alterations in Mice Fed a High-Fat Diet.
Topics: Amygdala; Animals; Case-Control Studies; Diet, High-Fat; Down-Regulation; Encephalitis; Hippocampus; Hypothalamus; Male; Metformin; Mice; Mice, Inbred C57BL; Pituitary Adenylate Cyclase-Activating Polypeptide; Prefrontal Cortex; Signal Transduction; Vasoactive Intestinal Peptide | 2021 |